2009•Nature MedicineOpen access

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans

Hiroshi Watanabe, Nagesh Chopra, Derek R. Laver, Hyun Seok Hwang, Sean S. Davies, Daniel E. Roach, Henry J. Duff, Dan M. Roden, Arthur A.M. Wilde, Björn C. Knollmann

Open full text 610 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 610 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Catecholaminergic polymorphic ventricular tachycardia, Flecainide, Ryanodine receptor, Ryanodine receptor 2, Ventricular tachycardia, Internal medicine, Medicine, Anti-Arrhythmia Agents

Back to paper search Browse research topics Original source

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans — Research Paper | ScholarLens